Maternal Fish Oil Supplementation Study in high risk pregnancies

Maternal Fish Oil Supplementation in high risk pregnancies and the effect on the infants' brain MRI findings and neurobehavioural outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN24068733

Enrollment

300

Registered

2011-09-02

Start date

2010-04-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maternal diabetes mellitus, pre-eclampsia, low birthweight Pregnancy and Childbirth Diabetes mellitus arising in pregnancy

Interventions

1. Fish oil supplements or placebo 2. MRI infant brain scan 3. Neuro-behavioural assessments of mother and infants

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: All pregnant women in high risk pregnancies with known or recent diagnosis of diabetes mellitus or those at risk of delivering a low birthweight baby cared for at the Chelsea & Westminster Hospital, London United Kingdom

Exclusion criteria

Exclusion criteria: 1. Fish allergy 2. Inability to speak english and refusal to use an interpreter 3. Non-resident in London 4. Unable to attend the follow up appointments

Design outcomes

Primary

Measure	Time frame
1. Infants MRI brain scan findings 2. Maternal lipid profile	—

Secondary

Measure	Time frame
1. Infant developmental outcomes 2. Maternal neurobehavioural outcomes	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026